Shop by goal

Popular compounds

Research resources

Recently viewed

How-to guides

Peptide Blog · Research Knowledge Hub

The Research Compounds Blog.

Straightforward explainers in plain English — how to handle vials, what researchers mean by “recovery” or “metabolic” signalling, and how to read lab paperwork. Written for curious readers and research / lab use ; not personal medical advice.

  • Library 40+ research guides
  • Sourced Peer-reviewed · regulator-cited
  • Updated Weekly drops
  • Framing Research use only
  • No articles matched . Try a compound name, a goal, or a how-to — or browse the shop.

    Latest drops New this week

    Hexarelin vs CJC-1295: GHSR/CD36 potency vs GHRH-R signalling

    Two ends of the same GH axis - the ghrelin-receptor/CD36 arm against the GHRH-receptor arm. Mechanism, half-life, desensitisation, DAC vs no-DAC, and why the literature co-studies them.

    Best peptides for muscle growth research (2026): the compounds labs actually study

    IGF-1 LR3, MGF/PEG-MGF, the GH-axis secretagogues and the BPC-157 + TB-500 recovery pair - mechanism by mechanism, honest about the human-trial gap and the WADA reality.

    Best peptides for testosterone research (2026): the HPG-axis compounds, explained

    Peptides do not boost testosterone like TRT - they are studied on the HPG axis. Kisspeptin, HCG, and why GH-axis peptides do not raise testosterone. Not a TRT substitute.

    Peptides and menopause research (2026): what the literature actually studies

    The honest map: no menopause treatment peptide exists, and menopause is a clinical matter for a doctor. Where research compounds do and do not intersect midlife physiology.

    Is retatrutide safe? What the research and the safety warnings show

    After news reports of "reta" being sold online despite its unapproved status: the Phase 2 adverse-event picture, the long-term unknowns, why self-sourcing is the real risk, and the research-use-only line.

    BPC-157: what the research actually says

    A research-first breakdown of the body protection compound - the preclinical-only evidence base, the peptide-vs-steroid question, and why recovery and hormonal claims overreach.

    Tesamorelin: what it is and what the research shows

    The GHRH analogue mechanism, the narrow approved visceral-fat indication, and where general fat-loss and longevity claims go too far.

    How to read a peptide Certificate of Analysis

    The label is the claim; the COA is the evidence. Mass spectrometry for identity, HPLC for purity, batch numbers for traceability - and the red flags that signal marketing over testing.

    TB-500 and Thymosin Beta-4: a research overview

    How TB-500 relates to (but differs from) Thymosin Beta-4, what the preclinical literature actually studies, the human-trial gap, and why it is prohibited in tested sport.

    What is tirzepatide? The 2026 research guide to the GLP-1 / GIP dual-agonist

    The molecule behind Mounjaro and Zepbound, plain. The dual-receptor mechanism, the SURMOUNT and SURPASS trial data, the licensed-drug vs research-compound distinction.

    Tirzepatide vs semaglutide: the 2026 research comparison

    The only published head-to-head trial (SURPASS-2), the obesity cross-trial picture, the cost reality, and the honest framing for research-grade vs licensed-drug contexts.

    Tirzepatide side effects: hair loss, GI & what the trial data actually shows

    Does tirzepatide cause hair loss? The SURMOUNT data, the telogen-effluvium mechanism, the GI side-effect picture, and the discontinuation rates - plain.

    Flagship explainer

    What are peptides? The elite’s 15-year anti-aging secret

    Short chains of amino acids that signal the body to repair, regenerate and regulate. Why billionaires and A-list actors have been running them privately since 2010 - and why the rest of the world is finally catching up.

    In the press & primary research

    The reporting and primary sources these guides reference. New-U is independent and not affiliated with these organisations - links are provided for research reference only and carry no endorsement either way.

    Browse by topic

    All articles by category 133 articles

    Six topic clusters covering everything from the Retatrutide trial data to lab how-tos. Use the chips below to jump.

    Weight Loss & GLP-1 Weight Loss & GLP-1 30 Retatrutide, tirzepatide and semaglutide research, trial data and regulatory status.

    Best Peptides for Weight Loss Research (2026)

    Retatrutide, tirzepatide, semaglutide, cagrilintide, tesamorelin and AOD-9604 - ranked by mechanism and reported trial data, honest about what's approved vs investigational. Research use only.

    Where to Buy Retatrutide in the USA: A Research-Use Sourcing Guide (2026)

    Retatrutide (LY3437943) is not FDA-approved and only available in the US as a research compound. A plain-English guide to FDA framing, supplier checks, public COAs, USD pricing and tracked US delivery.

    Peptide Search Demand in Australia: A 2026 Trend Report

    Australian search interest in research peptides has climbed sharply, led by GLP-1 compounds. What Australian researchers search for, why, and the TGA framing.

    The Rising Demand for Research Peptides in the UK: A 2026 Search-Trend Report

    UK search interest in research peptides has climbed sharply since 2023. What UK researchers are searching for, why, the MHRA framing, and how the research-use market works.

    Research Peptide Search Demand in the USA: A 2026 Trend Report

    US search interest in research peptides surged through the GLP-1 era and the FDA compounding shake-up. What American researchers search for, why, and the FDA framing.

    Retatrutide Search Demand in the UK: The 2026 Surge, Explained

    UK search interest in retatrutide has climbed from near-zero to a Google Trends Breakout term since 2023. What's driving the UK surge, the MHRA framing, and how researchers source it.

    Why "Reta" Searches Are Surging in the USA: A 2026 Search-Trend Report

    Search interest in retatrutide has gone from near-zero to a Google Trends Breakout term in the USA since 2023. What's driving it, what the data means, and how researchers source it.

    Tirzepatide ("Tirz") Search Demand in the USA: A 2026 Trend Report

    US search interest in tirzepatide climbed steeply from 2022. Why an FDA-approved drug also drives research-compound interest, and the framing that matters.

    Amycretin: Research Guide to Novo Nordisk's Amylin + GLP-1 Agonist

    Mechanism, Phase 1b/2a and Phase 2 data, and the research-compound posture for amycretin - Novo Nordisk's unimolecular amylin + GLP-1 agonist, oral and injectable.

    Beyond GLP-1: The Next Obesity Research Wave

    MariTide, CagriSema, amycretin, survodutide, petrelintide and orforglipron - the next obesity-research wave, mechanism by mechanism, with the latest trial data. Research use only.

    CagriSema (Cagrilintide + Semaglutide): Research Guide to the Amylin + GLP-1 Combination

    Mechanism, the REDEFINE Phase 3 data and the research-compound posture for CagriSema, Novo Nordisk's fixed-dose cagrilintide + semaglutide combination.

    MariTide (Maridebart Cafraglutide): Research Guide to Amgen's Monthly GLP-1 / GIP Antagonist

    Mechanism, Phase 2 weight-loss data and the research-compound posture for MariTide (maridebart cafraglutide, AMG 133), Amgen's once-monthly peptide-antibody conjugate.

    Orforglipron: Research Guide to the First Oral Non-Peptide GLP-1

    Mechanism, the ATTAIN Phase 3 data and the research context for orforglipron (LY3502970), Eli Lilly's once-daily oral small-molecule GLP-1 agonist.

    Petrelintide (ZP8396): Research Guide to the Long-Acting Amylin Analogue

    Mechanism, the ZUPREME-1 Phase 2 data and the research-compound posture for petrelintide (ZP8396), Zealand Pharma and Roche's long-acting amylin analogue.

    Survodutide (BI 456906): Research Guide to the GLP-1 / Glucagon Dual Agonist

    Mechanism, the SYNCHRONIZE Phase 3 obesity data, the MASH Breakthrough Therapy status, and the research-compound posture for survodutide (BI 456906).

    Is Retatrutide Safe? What Research Shows | New-U

    Retatrutide is unapproved and now widely reported as sold online. What the Phase 2 safety data shows, the unknowns, and why self-sourcing is the real risk.

    FDA Moves to End Mass-Compounded GLP-1s: What the 503B Proposal Means

    The FDA's April 2026 proposal to remove semaglutide, tirzepatide and liraglutide from the 503B bulks list, explained - plus the June 2026 comment deadline.

    Retatrutide: Research Guide to the Triple GLP-1 / GIP / Glucagon Agonist

    A research-side guide to retatrutide (LY3437943) - mechanism, Phase 2 weight-reduction data, the TRIUMPH Phase 3 programme, and the Retatrutide research-compound posture.

    Semaglutide: Research Guide to the GLP-1 Single Agonist

    A research-side guide to semaglutide - mechanism, half-life, STEP / SUSTAIN trial data, oral vs injectable, and the Semaglutide research-compound posture.

    Tirzepatide: Research Guide to the Dual GLP-1 / GIP Agonist

    A research-side guide to tirzepatide (LY3298176) - mechanism, half-life, SURPASS / SURMOUNT trial data, comparison with semaglutide and retatrutide, and the Tirzepatide research compound posture.

    Tirzepatide Side Effects: Hair Loss, GI & What the Trial Data Actually Shows

    Does tirzepatide cause hair loss? The SURMOUNT data, the telogen-effluvium mechanism, GI side effects, plain.

    Tirzepatide vs Semaglutide: Research | New-U

    Head-to-head trial data (SURPASS-2), mechanism difference, cost reality, and the honest comparison framing.

    What is Tirzepatide? The 2026 Research Guide to the GLP-1 / GIP Dual-Agonist

    Dual GLP-1 / GIP receptor agonist - the molecule behind Mounjaro and Zepbound. Mechanism, trial data, regulatory status, plain.

    Retatrutide Phase 3: The TRIUMPH Trials | New-U

    Five Phase 3 trials, five indications. Endpoints, timelines and what to watch in 2026/27.

    Where Buyers Source Retatrutide (2026) | New-U

    Retatrutide is unapproved. Demand has shifted online. The 4 channels, the COA reality, the counterfeit risk.

    Retatrutide Weight Loss: 24% at 48 Weeks - What the Trial Data Actually Shows

    The largest weight-loss figure in the published pharmacological literature. Numbers, dose-response, honest comparison.

    What is Retatrutide? Research Guide | New-U

    A single molecule hitting GLP-1, GIP and glucagon receptors. The mechanism, the trial data, the regulatory truth.

    Where to Buy Retatrutide in the UK: A Research-Use Sourcing Guide

    Retatrutide (LY3437943) is unlicensed in the UK and only available as a research compound. A plain-English guide to MHRA framing, supplier checks, GBP pricing and tracked UK delivery.

    Is Ozempic a Peptide? GLP-1 Receptor Agonists, Explained

    Semaglutide is a peptide and a GLP-1 receptor agonist. What GLP-1 is, how the class works, and how research-use peptides differ from approved medicines.

    Semaglutide vs Tirzepatide: Key Differences Explained

    Side-by-side comparison of two leading metabolic peptides - mechanisms, selectivity, and published research.

    Sports & Recovery Sports & Recovery 17 BPC-157, TB-500 and the peptide research literature mapped onto golf, Hyrox, CrossFit, cycling and the strength sports.

    BPC-157 in Equine Soft-Tissue Research: Mechanism, Evidence & the Racing Reality

    The real angiogenic and fibroblast-migration mechanisms behind BPC-157's 'soft-tissue' claims, why the evidence is preclinical, and the racing medication rules sellers skip.

    TB-500 in Equine Recovery Research: What the Science Actually Studies

    Why horses are studied as a tendon-injury model, the real tissue-repair mechanisms behind TB-500, the human-to-horse evidence gap, and the racing anti-doping reality.

    TB-500 in Sport: Banned Without a Performance Claim - and How Labs Detect It

    Why a recovery peptide is prohibited at all times in tested sport, where TB-500 sits on the WADA list, and the metabolism science anti-doping labs use to detect it.

    BPC-157 + TB-500 Stack Protocol: Research Guide

    Complete guide to BPC-157 and TB-500 stacking: mechanism synergy, timing, dosing, reconstitution, and pre-clinical evidence.

    Shoulder Injury Recovery with Peptides: BPC-157 & TB-500

    Peptide protocols for shoulder injury recovery: BPC-157 and TB-500 for rotator cuff, ACL, tendon damage. Pre-clinical research, dosing, injection protocols, and recovery timeline.

    TB-500 and Thymosin Beta-4: A Research Overview

    A research-first overview of TB-500 - how it relates to Thymosin Beta-4, what the preclinical literature actually studies, the human-trial gap, and why it is prohibited in tested sport.

    Climbing & Pulley Injuries: Peptide Recovery Research, Mapped

    The A2 pulley rupture is the climber's ACL. Why BPC-157 is the most-discussed peptide in climbing forums, and the IFSC anti-doping reality.

    Marathon & Distance Running: Peptide Recovery Research, Mapped

    30,000 ground impacts, eccentric quad damage, mitochondrial debt. The peptide-recovery research literature mapped onto the 26.2-mile recovery curve.

    MMA & Combat Sports: Peptide Recovery Research, Mapped

    The peptide-research overlap with combat-sports recovery, and the USADA / VADA / WADA framing every fighter needs.

    Powerlifting & Strength Training: Peptide Recovery Research, Mapped

    The peptide-research overlap with powerlifting recovery - tendon, lumbar, CNS - and the IPF / USPA testing reality.

    BPC-157 & Tattoo Healing Research | New-U

    A research look at why BPC-157 keeps appearing in tattoo recovery conversations - skin barrier repair, vascularisation, collagen remodelling.

    CrossFit: Peptide Recovery Research | New-U

    High-intensity volume meets the peptide soft-tissue literature. A research-framed map.

    Cycling: Peptide Recovery Research | New-U

    IT band, lumbar disc, mitochondrial efficiency - the peptide endurance-recovery literature, plain.

    Hyrox & Peptide Recovery: A Research Look at the Sport's Soft-Tissue Toll

    Eight runs, eight stations, one body. The peptide recovery research mapped onto the Hyrox gauntlet.

    Peptides & Bodybuilding: A Research Map of the Compounds in the Conversation

    The GH axis, recovery, fat-loss and connective-tissue compounds - what the literature shows, and what's WADA-prohibited.

    TB-500 & Golf Recovery: A Research Look at the Game's Soft-Tissue Toll

    Five structures take the load of every swing. The TB-500 soft-tissue research literature, plain - and where it sits in the recovery conversation.

    Inside the Private Clinics: Peptide Protocols of the Top 1%

    $30,000-a-year longevity clinics. The exact compounds Silicon Valley and A-list actors have been running for over a decade.

    Skin & Hair Skin & Hair 7 GHK-Cu, Melanotan and the dermatology research literature: collagen density, copper peptide mechanism, hair follicle research.

    GHK-Cu for Hair Loss: Research Guide to the Copper Peptide

    Complete research guide to GHK-Cu and hair loss: mechanism, dosing, topical vs systemic, pre-clinical evidence, and timeline expectations.

    GHK-Cu Dosage Guide: How Much, How Often, Topical vs Injection

    What the published research literature says about GHK-Cu dosage - topical %, subcutaneous μg ranges, frequency, reconstitution, safety and onset.

    Melanotan-2, Sweden & Melanoma Research | New-U

    Sweden has one of the highest melanoma incidence rates in Europe. The Nordic epidemiology, the published primary-prevention evidence, and where Melanotan-2 sits in the melanocortin research landscape - including the case reports that complicate the 'tanning shortcut' narrative.

    GHK-Cu & Skin Thickness Research | New-U

    A tattoo artist had to switch to a deeper needle mid-session and noted the skin felt thicker - without knowing GHK-Cu was being studied. The dermal-density literature, plain.

    Peptides for Skin & Collagen: What the Research Shows

    Signal peptides, copper peptides and collagen peptides - what the dermatology literature actually supports, in plain English.

    Peptides & Hair Growth: What the Research Shows

    Copper peptides and hair-follicle science - what is studied, what is not established, and why research framing matters.

    GHK-Cu: The Copper Peptide Driving Explosive Research Interest

    With search interest up over 1,000% YoY, GHK-Cu is one of the most studied regenerative peptides. Here's what the research shows.

    Lab How-To Lab How-To 13 Reconstitution, storage, and COA reading - everything you need to handle research-grade vials correctly.

    Free Peptide Reconstitution Calculator

    Enter vial mg, water mL, and desired dose - instantly see units to draw. Presets for BPC-157, Semaglutide, TB-500 and more.

    How Research Peptides Are Made: From Lab Synthesis to Your Door

    The eight-stage journey from solid-phase synthesis to shipped vial - synthesis, purification, lyophilisation, QC, filling, third-party testing, storage - and where quality is won or lost.

    TikTok Peptide Sellers: How to Spot Hype, Resellers & Quick-Buck Marketing

    Popularity isn't credibility. How to see past viral parcels, luxury cars and urgency countdowns - and the evidence-based questions to ask a peptide supplier instead.

    Why Buying Single Peptide Vials Usually Costs You More

    A single vial looks cheaper - until you count the relabelling, reseller markups and repeat shipping. How to compare cost-per-mg and testing instead of the price tag.

    How Much Do Research Peptides Cost? | New-U

    Sealed 10-vial packs broken down by price-per-vial and price-per-mg, and why the higher-mg tiers are the lowest cost per mg. Research use only.

    Peptide Sourcing & Verification Guide: Spot Counterfeit Peptides

    How to verify peptide authenticity: inspect vials, review Certificates of Analysis, confirm supplier credentials, and detect counterfeit peptides.

    How to Read a Peptide Certificate of Analysis Before You Trust a Supplier

    The label tells you the claim; the COA shows whether it has been tested. Mass spectrometry for identity, HPLC for purity, batch numbers for traceability - and the red flags that signal marketing over evidence.

    Bacteriostatic Water for Peptide Reconstitution: The Complete Research Guide

    The standard solvent for research-peptide reconstitution — what it is, bacteriostatic vs sterile water, how much to add, shelf life, storage and the mixing math.

    How to Choose a Peptide Supplier: The Research-Buyer's Quality Checklist

    The per-batch CoA, third-party HPLC/mass-spec, reference standards and grey-market red flags - a research-literate checklist for vetting a peptide supplier.

    How to Buy Research Peptides in the US & UK: Sourcing, Purity & Compliance

    Vetting suppliers, the Certificate of Analysis, HPLC purity and the research-use-only framing - a research-literate sourcing guide.

    How to Read a Certificate of Analysis (COA)

    Understanding HPLC purity, mass spectrometry, endotoxin levels, and every section of a peptide COA.

    How to Store Peptides - Temperature, Light & Shelf Life

    Optimal storage for lyophilised and reconstituted peptides. Temperature, light, moisture control, and shelf life by peptide type.

    How to Reconstitute Peptides: Step-by-Step Guide

    Learn how to properly reconstitute lyophilised peptides with bacteriostatic water. Complete guide with dosage calculator.

    Science & Education Science & Education 31 What peptides actually are, how they signal, the elite-protocol context, and the most-researched compounds in 2026.

    Peptide How-To Guides - Free 3-Part Series

    Reconstitute, calculate dosage, and store peptides. Free interactive calculator + step-by-step guides.

    5-Amino-1MQ: NNMT-Inhibitor Research Guide (2026)

    A small-molecule NNMT inhibitor studied for fat-cell metabolism and NAD+/SAM preservation - mechanism, the preclinical evidence, and how it differs from peptides. Research use only.

    Selank: Anxiolytic Nootropic Peptide Research Guide (2026)

    A tuftsin-derived heptapeptide studied as a non-sedating anxiolytic - GABAA modulation, BDNF, the medazepam comparison and Selank vs Semax. Research use only.

    Peptides and Menopause Research | New-U

    An honest research-landscape map - there is no menopause 'treatment' peptide. What appears in the midlife and hormonal-change research conversation, and where the evidence stops. Research use only.

    Best Peptides for Muscle Growth Research (2026)

    IGF-1 LR3, MGF/PEG-MGF, the GH-axis secretagogues and the recovery pair - mechanism by mechanism, with the human-trial gap and the WADA reality. Research use only.

    Best Peptides for Testosterone Research (2026): The HPG-Axis Compounds

    Peptides do not boost testosterone like TRT - they are studied on the HPG axis. Kisspeptin, HCG, and the honest research framing. Research use only.

    Hexarelin vs CJC-1295: GHSR/CD36 Potency vs GHRH-R Signalling

    The ghrelin-receptor/CD36 mechanism against the GHRH-receptor pathway - half-life, desensitisation, DAC vs no-DAC, and why the two are co-studied. Research use only.

    The Half-Life Arms Race: Why Peptides Are Engineered to Last

    Nearly every peptide program optimizes for duration. The opposite frontier - rhythm, not persistence - sits almost empty. A research-use field map.

    Peptide Side Effects Comparison: Research Guide

    Comprehensive peptide side effects comparison chart: BPC-157, TB-500, GHK-Cu, MOTS-c, ipamorelin. Pre-clinical safety data, injection site effects, systemic toxicity, and human evidence gaps.

    BPC-157: What the Research Actually Says

    A research-first breakdown of BPC-157 - the body protection compound, the preclinical evidence base, the human-trial gap, and why the honest answer separates interest from proof.

    Tesamorelin: What It Is and What the Research Shows

    A GHRH analogue with a genuine but narrow approved use. What the visceral-fat research shows, how tesamorelin differs from recovery peptides, and why general fat-loss and longevity claims overreach.

    Scientists Map 9 Peptides for Healthy Aging: A 2026 Peer-Reviewed Review

    A 2026 Frontiers in Aging review maps nine therapeutic peptides onto the hallmarks of aging. What the authors found - and the gaps they flag.

    PT-141 (Bremelanotide): a research guide to the melanocortin agonist

    How PT-141 works, nasal spray administration, clinical evidence, and how it compares to traditional sexual dysfunction treatments.

    Hexarelin vs Ipamorelin: Potency vs Selectivity

    Both hit the ghrelin receptor — but hexarelin pushes harder (and reaches the heart via CD36) while ipamorelin stays clean and selective. A research comparison.

    IGF-1 DES vs IGF-1 LR3: A Research Guide to the Two Modified IGF-1 Analogues

    Des(1-3) vs Long R3 IGF-1 - structure, half-life, binding-protein affinity, the recombinant-protein research context, and the anti-doping reality. Research use only.

    Ipamorelin vs Sermorelin: A Research Comparison

    Two different receptors, one shared goal — releasing growth hormone. How the selective ghrelin agonist ipamorelin and the GHRH analogue sermorelin differ, and why they're studied together.

    Peptides and Stem Cells: How They Work Together in Regenerative Medicine Research

    Signalling peptides, peptide hydrogels and scaffolds, and growth factors - how the peptide literature intersects with stem-cell and regenerative-medicine research.

    Tesamorelin vs Sermorelin: Two GHRH Analogues Compared

    Both prompt the pituitary through the GHRH receptor — but tesamorelin is the stabilised, more potent molecule studied for visceral fat, while sermorelin is the classic GHRH 1-29 fragment. A research comparison.

    BPC-157: A Research Guide to the Body Protective Compound

    A neutral research-side guide to BPC-157 - mechanism, pre-clinical evidence, the human-trial gap, the Wolverine stack with TB-500, and the research-compound posture.

    CJC-1295 & Ipamorelin: Research Guide to the GHRH + GHRP Pair

    A research-side guide to CJC-1295 (modified GHRH 1-29) and ipamorelin (selective ghrelin-receptor pentapeptide) - mechanisms, DAC vs no-DAC, synergy and the research-compound posture.

    Tesamorelin: Research Guide to the GHRH Analogue

    A research-side guide to tesamorelin - mechanism, NIH visceral-adipose-tissue data, comparison with CJC-1295 and sermorelin, and the research-compound posture.

    Amino Acids vs Peptides: The Building-Block Relationship

    Amino acids are the monomers; peptides are short chains of them joined by peptide bonds. The plain-English structural relationship, research framed.

    The Most-Researched Peptides of 2026: A Research-Interest Landscape

    A neutral map of which research peptides are drawing attention in 2026 - trend commentary attributed, no human-use claims.

    Can You Combine Peptides? Stacking, Skincare vs Research, Explained

    Two different questions - topical skincare layering vs research-reagent handling. Why combination protocols are human-use guidance we do not provide.

    Peptide Research Compounds: Quality, Testing & Buying Guide

    How peptide quality is actually verified - HPLC/LC-MS, the Certificate of Analysis, lyophilised handling, storage, supplier selection, and global shipping. Research use only.

    What Peptides Do Celebrities Use? 2026 List (Sourced)

    The sourced version of every 'what peptide does [celebrity] use' search - BPC-157, NAD+, the Wolverine stack - attributed to ELLE, TIME, The Times, Yahoo and AOL.

    TRT vs Peptides: How the Comparison Is Framed

    A neutral explainer on how clinics and the literature frame testosterone replacement therapy versus peptide approaches. Research context only.

    What Is Peptide Therapy? How Clinics & the Literature Frame It

    A neutral explainer on how the term 'peptide therapy' is used - approved peptide medicines vs investigational compounds, and why the language is regulated.

    MOTS-c: The Mitochondrial Peptide Researchers Are Watching

    MOTS-c is a mitochondrial-derived peptide at the intersection of metabolic regulation and longevity research.

    Peptide Benefits: What the Research Actually Shows

    Every major peptide benefit traced back to peer-reviewed studies, with the mechanisms that make each one work.

    What Are Peptides? The Elite's 15-Year Anti-Aging Secret

    Short chains of amino acids that tell the body to heal, repair and regenerate. Inside the science the top 1% have quietly relied on for over a decade.

    Regulatory & Safety Regulatory & Safety 25 FDA approval status, US / UK / EU legality, safety frameworks, clinician perspectives, and the industry analysis pieces.

    BPC-157 and TB-500 Under FDA Review: A New Era for Regenerative Peptide Research

    On July 23, 2026, the FDA's compounding advisory committee discusses BPC-157 and TB-500 bulk substances. What it means for regenerative peptide research - and why a review is not an approval.

    FDA Peptide Reclassification 2026: What Changed, and Why

    From Category 2 prohibition (2023) to a fresh 503A review (2026): the notice, the 12 peptides, the lawsuits, the policy push, and what the July 2026 PCAC meeting decides.

    FDA Peptide Review 2026: What the July Meeting Could Mean

    The FDA's Pharmacy Compounding Advisory Committee reviews BPC-157, TB-500, KPV, MOTS-c, Emideltide (DSIP), Semax and Epitalon on July 23-24, 2026. A review is not an approval - here is what it actually means.

    Is BPC-157 Banned? What the FDA Has and Hasn't Done

    Not exactly. BPC-157 is a research-use-only compound the FDA's 2023 compounding review kept off the 503A Bulks List for human use - and it returns for discussion in July 2026.

    Is BPC-157 FDA Approved? The 2026 Regulatory Status

    No - BPC-157 is a research compound, not an FDA-approved drug. The 2026 status explained, including the July 2026 503A compounding review.

    Is Epitalon FDA Approved? The 2026 Regulatory Status

    No - Epitalon (Epithalon) is a research compound, not an FDA-approved drug. The 2026 status and the July 2026 review, explained.

    Is the FDA Changing Its Position on Peptides? July 2026 Review Explained

    A compounding-list review is not a change of FDA position. What the July 23-24, 2026 advisory committee meeting really means for BPC-157, TB-500, Semax and Epitalon.

    Is Semax FDA Approved? The 2026 Regulatory Status

    No - Semax is a research compound in the US, not an FDA-approved drug (though it is a registered medicine in Russia). The 2026 status and July 2026 review, explained.

    Is TB-500 FDA Approved? The 2026 Regulatory Status

    No - TB-500 is a research compound related to thymosin beta-4, not an FDA-approved drug. The 2026 status, the July 2026 review and the WADA sport ban, explained.

    KPV Peptide and the FDA: What the July 2026 Review Means

    KPV - the anti-inflammatory tripeptide derived from alpha-MSH - is on the FDA's July 2026 compounding agenda. What it is, the research context, and why a review is not an approval.

    Peptides, the FDA and the Media: What Viewers Need to Understand

    As peptides become a bigger public-health story, audiences need clearer information about BPC-157, TB-500, Semax, Epitalon and the FDA's 2026 review. FDA review is not approval.

    Semax, Epitalon and DSIP: Neuro-Longevity Peptides in the FDA's 2026 Review

    On July 24, 2026, the FDA's compounding advisory committee discusses Semax, Epitalon and Emideltide (DSIP). What it could mean for neuro-longevity peptide research - and why a review is not an approval.

    Why Peptides Could Become the Next Big Mainstream Health News Story

    As the FDA prepares to review peptide-related bulk substances in July 2026, peptides are moving toward mainstream health news. Why it matters - and how to read the coverage responsibly.

    Peptide Injections: What They Are, What the 2026 Research Shows, and the Safety Questions

    FDA-approved injectables vs unapproved research compounds, what the 2026 press wave reported, and the safety questions doctors raise - a research-literate explainer.

    Pharmaceutical-Grade vs Research-Grade Peptides: What the Labels Actually Mean

    GMP and pharmacopoeia standards vs research-use-only purity, why 'pharma grade' is often marketing, and how to read what's really in the vial.

    How the Research Compound Industry Is Modernising in 2026

    Crypto rails, AI discoverability and per-batch supply-chain transparency are reshaping the research compound space. The full-stack 2026 explainer.

    Weekend Athletes & Research Compounds: Why the RUO Frame Matters

    The honest answer to the grassroots recovery question: research compounds are not a recovery option for amateur athletes. The RUO framing, explained.

    Europe's Rise in Casino Game Providers and Peptide Innovation

    Why Europe is setting the global pace in both iGaming and peptide biotech - the regulatory maturity, consumer psychology and brands defining 2026.

    Are Peptides Legal in the UK? The MHRA Position, Explained

    Peptides are legal to buy and possess for research in the UK, but the MHRA bars marketing them for human use unless licensed as medicines. The research-use line, explained.

    The 2023 FDA Peptide Compounding Decision, Explained

    What the FDA's compounding decision actually said, the safety concerns behind it, and why it underlines that research material is not for human use.

    What Clinicians Say About Injectable Peptides

    Physicians, via the AMA, on limited FDA review, animal-only evidence and open dosing questions - and why that is what 'research use only' means.

    Are Peptides Legal? US, EU & UK Status, Explained

    How research peptides are regulated by jurisdiction - medicinal-product status, the EMA framework, and what 'research use only' actually means.

    Are Peptides Safe? What the Research Actually Says

    How peptide safety is actually assessed - purity, contamination, the Certificate of Analysis, and what 'research use only' means.

    Are Peptides Steroids? The Difference, Explained

    Peptides and steroids are different chemical and mechanistic classes - here is the plain-English difference.

    Peptides & the FDA: The Approval Pipeline Explained

    7 peptides are FDA-approved. 40+ are in active clinical trials. A complete map of the regulatory pipeline.

    Other Other 10 Articles not yet categorised - add them to scripts/sync-blog-index.mjs CATEGORIES.

    Trump, Retatrutide and the Obesity-Drug Demand Story

    The White House denies Trump got compassionate-use access to retatrutide. What the story says about demand for an experimental obesity drug still in trials - and why research use only means not for human use.

    The Unregulated Peptide Grey Market: What the Telegraph Investigation Reveals

    A Telegraph investigation into the unregulated peptide grey market - influencers, contaminated product, and the misuse of the "research use only" label. What it means for responsible, research-use-only sourcing.

    Beyond Weight Loss: The Next GLP-1 Battle | New-U

    The next phase of GLP-1 research is about tolerability, muscle preservation and long-term adherence, not just headline weight-loss percentages.

    Peptide News, COAs, Purity and Traceability | New-U

    As peptide research goes mainstream, what a COA should show and why purity and traceability are non-negotiable for research compound verification.

    GLP-1 Access Is Becoming a Coverage Problem | New-U

    With Cigna dropping GLP-1 obesity coverage, access and affordability are now separate from the science. A neutral market analysis.

    July 2026 FDA Peptide Meeting: What to Know | New-U

    The FDA's July 23-24, 2026 compounding committee will discuss BPC-157, TB-500, KPV, MOTS-c, Semax and Epitalon. A neutral regulatory explainer.

    Monthly GLP-1: Berobenatide Research | New-U

    Pfizer presented berobenatide data on monthly GLP-1 dosing. Here is what long-acting metabolic research signals about adherence, tolerability and the pipeline.

    Oral vs Injectable GLP-1 and Peptide Research | New-U

    Oral small-molecule GLP-1s and peptide-based injectables differ in manufacturing, storage and research models. A high-level educational explainer.

    Research Use Only Is Not a Loophole | New-U

    FDA GLP-1 warnings show why research use only must be a real compliance boundary, not marketing cover. A guide to compliant supplier language.

    Retatrutide Phase 3: The Triple-Hormone GLP-1 Story | New-U

    Retatrutide Phase 3 data was presented at the 2026 ADA Sessions. Here is a research-focused look at why triple-hormone agonists now lead the GLP-1 conversation.

    Guides & tools

    Premium research peptides at >99% HPLC-verified purity, third-party tested by Janoshik Analytical with a Certificate of Analysis on every lot. Shipped lab-direct, discreet and cold-chain, worldwide. For laboratory research use only.

    Shop

  • All Peptides
  • Fat-Loss Peptides
  • Skin & Anti-Aging
  • Stacks & Protocols
  • Compare Vials
  • Peptide 101
  • Learn

  • Research Blog
  • How-To Guides
  • Certificates of Analysis
  • Community Forum
  • Company

  • About Us
  • Contact
  • FAQ
  • Affiliate Program
  • VIP Club
  • Support

  • Shipping & Delivery
  • Pay with Crypto
  • Live Crypto Prices
  • Refund Policy
  • Privacy
  • Terms
  • Ways to Pay

  • Google Pay
  • Apple Pay
  • Venmo
  • PayPal
  • Crypto
  • Cash App
  • Credit Card
  • SEPA
  • Shop by Compound

  • BPC-157
  • TB-500
  • GHK-Cu
  • Tesamorelin
  • Retatrutide
  • Semaglutide
  • Tirzepatide
  • CJC-1295 (without DAC)
  • View all compounds →
  • Shop by Goal

  • Fat Loss
  • Growth Hormone
  • Muscle Growth
  • Tissue Repair
  • Recovery
  • Anti-Aging
  • Cognitive
  • Accessories
  • Ships worldwide

  • United Kingdom
  • Australia
  • Canada
  • Canada (FR)
  • Ireland
  • Malta
  • Germany
  • France
  • Spain
  • Italy
  • Netherlands
  • Portugal
  • Greece
  • Austria
  • Poland
  • Sweden
  • Finland
  • Denmark
  • Norway
  • Croatia
  • Slovakia
  • Slovenia
  • Estonia
  • Latvia
  • Lithuania
  • Czechia
  • Hungary
  • Romania
  • Bulgaria
  • Belgium
  • Belgium (FR)
  • Luxembourg
  • USA
  • Research use only (RUO). All products are sold strictly for laboratory and research purposes — not for human or veterinary consumption. Purchasers must be 21 or older.

    All rights reserved. Copyright of New-U held with Hilxera Distribution Services LLC 2026.

    Website & business operated by Hilxera Distribution Services LLC. Registered in Wyoming, ID: 2026-001928701.

    © 2026 New-U Research Compounds · new-u.io · @new.u.io

    Research use only — not for human consumption. All products are supplied strictly for laboratory research purposes.

    © 2026 New-U Research Compounds · new-u.io — Copyright held with Hilxera Distribution Services LLC. All rights reserved.